Your browser doesn't support javascript.
loading
The reactivation time in the treatment of AMD: a forgotten key parameter?
Real, J P; Luna, J D; Palma, S D.
Affiliation
  • Real JP; Unidad de Investigación y Desarrollo en Tecnología Farmacéutica (UNITEFA), CONICET and Departamento de Ciencias Farmacéuticas, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, Ciudad Universitaria, 5000, Córdoba, Argentina.
  • Luna JD; Vitreo-Retinal Department, Centro Privado de Ojos Romagosa SA - Fundación VER, Deán Funes 429/432, Córdoba, Argentina.
  • Palma SD; Unidad de Investigación y Desarrollo en Tecnología Farmacéutica (UNITEFA), CONICET and Departamento de Ciencias Farmacéuticas, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, Ciudad Universitaria, 5000, Córdoba, Argentina. sdpalma@fcq.unc.edu.ar.
Graefes Arch Clin Exp Ophthalmol ; 256(6): 1079-1087, 2018 Jun.
Article in En | MEDLINE | ID: mdl-29675724
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Visual Acuity / Tomography, Optical Coherence / Wet Macular Degeneration / Ranibizumab Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies / Systematic_reviews Limits: Humans Language: En Journal: Graefes Arch Clin Exp Ophthalmol Year: 2018 Type: Article Affiliation country: Argentina
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Visual Acuity / Tomography, Optical Coherence / Wet Macular Degeneration / Ranibizumab Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies / Systematic_reviews Limits: Humans Language: En Journal: Graefes Arch Clin Exp Ophthalmol Year: 2018 Type: Article Affiliation country: Argentina